Biotech Values

[poorgradstudent]

re: ctic

This whole game of updating the events at monthly intervals is getting me annoyed.

You can't solve anything from the blended data that they're reporting, so it's really a way for CTIC to juice up the *ahem* naive investors. (I use that term with hesitation since, in the stock market, naive is relative.)

The skeptic in me is thinking that Bianco is milking the "longer than expected blended median survival" to increase share price and put forward another offering.

A success in Stellar 3 will boost the share price. However, they really need to follow it up with an additional success in Stellar 2 or 4. Otherwise, the market will pummel them somewhat post-approval (a la OSIP) because the on-label population will be restricted to begin with.